The stock hit an intra-day high of Rs 1,129 in early morning trade and surged 23% in past two trading sessions from Rs 921 on July 19, 2016.
Wockhardt said, upon completion of an inspection, US FDA provides inspected establishments an inspected report, called an EIR.
However, receipt of EIR does not changes our exiting status for the concerned units. Reciept of EIR does not materially change the status of import alert for the concerned manufacturing units for the US market, it added.
The company made a clarification on the news appeared on moneycontrol.com, July 21, 2016- "Chikalthana gets EIR clearance with no observations".
At 02:55 PM, the stock was down 3.5% at Rs 1,001 on the BSE. A combined 8.53 million shares changed hands on the counter on the BSE and NSE.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)